Intuniv and Sleep disorder - a phase IV clinical study of FDA data

Summary:

Sleep disorder is reported as a side effect among people who take Intuniv (guanfacine hydrochloride), especially for people who are male, 2-9 old, have been taking the drug for 6 - 12 months also take Concerta, and have Asthma.

The phase IV clinical study analyzes which people have Sleep disorder when taking Intuniv. It is created by eHealthMe based on reports of 3,469 people who have side effects when taking Intuniv from the FDA, and is updated regularly.

What is Intuniv?

Intuniv has active ingredients of guanfacine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 3,959 Intuniv users. Check the latest studies of Intuniv.

What is Sleep disorder?

Sleep disorder is found to be associated with 2,103 drugs and 2,938 conditions by eHealthMe. Check the latest studies of Sleep disorder.

On Jul, 11, 2026

3,469 people reported to have side effects when taking Intuniv.
Among them, 28 people (0.81%) have Sleep disorder.

Among these 28 people:

How long have people been on Intuniv when they have Sleep disorder? *

What is the gender of people who have Sleep disorder when taking Intuniv? *

female: 33.33 %
male: 66.67 %

What is the age of people who have Sleep disorder when taking Intuniv? *

What are other drugs people take besides Intuniv? *

Concerta: 5 people, 17.86%
Dupixent: 4 people, 14.29%
Vyvanse: 3 people, 10.71%
Symbicort: 3 people, 10.71%
Zoloft: 2 people, 7.14%
Methylphenidate Hydrochloride: 2 people, 7.14%
Cetirizine Hydrochloride: 2 people, 7.14%
Flonase: 2 people, 7.14%
Klonopin: 2 people, 7.14%
Melatonin: 2 people, 7.14%

What are other side effects people have besides Sleep disorder? *

Abnormal Behavior: 6 people, 21.43%
Aggression: 5 people, 17.86%
Anger: 4 people, 14.29%
Suicidal Ideation: 4 people, 14.29%
Stress And Anxiety: 4 people, 14.29%
Sleep Talking (talking during sleeping): 3 people, 10.71%
Dyspnea (difficult or laboured breathing): 3 people, 10.71%
Drowsiness: 3 people, 10.71%
Sleep Walking (walking during sleep): 3 people, 10.71%
Depression: 3 people, 10.71%

What are the existing conditions these people have? *

Asthma: 3 people, 10.71%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 2 people, 7.14%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 3.57%
Multiple Allergies (allergy to multiple agents): 1 person, 3.57%
Mood Swings (an extreme or rapid change in mood): 1 person, 3.57%
Hidradenitis (chronic disease of a type of sweat gland): 1 person, 3.57%
Foetal Alcohol Syndrome (a pattern of mental and physical defects that can develop in a foetus in association with high levels of alcohol consumption in pregnancy): 1 person, 3.57%
Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain): 1 person, 3.57%
Autism (a mental condition, present from early childhood, characterized by difficulty in communicating and forming relationships with other people and in using language and abstract concepts): 1 person, 3.57%
Acne (skin problems that cause pimples): 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Intuniv and have Sleep disorder?

- Check whether Sleep disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Intuniv:

Intuniv (3,959 reports)

Sleep disorder treatments and more:

Sleep disorder (167,338 reports)

Browse all side effects of Intuniv:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sleep disorder:

Sleep disorder (2,103 drugs)

Browse all the conditions that are associated with Sleep disorder:

Sleep disorder (2,938 conditions)

Related publications that referenced our studies

Lin SC, Su YC, Huang YS, Lee CC, "Zolpidem increased cancer risk in patients with sleep disorder: A 3-year follow-up study", Journal of Medical Sciences, 2016 Mar .
Lin SC, Su YC, Huang YS, Lee CC, "Zolpidem increased cancer risk in patients with sleep disorder: A 3-year follow-up study", Journal of Medical Sciences, 2016 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on guanfacine hydrochloride (the active ingredients of Intuniv) and Intuniv (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.